The Breast Tumor Microenvironment: A Key Player in Metastatic Spread
Lucas E L Terceiro1, Chidalu A Edechi1, Nnamdi M Ikeogu2
1Department of Pathology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
Cancers
|October 13, 2021
Summary
The tumor microenvironment significantly influences breast cancer progression and metastasis through cell interactions. Understanding these interactions and stromal cell markers can guide new therapeutic strategies.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- The tumor microenvironment (TME) is crucial for breast cancer initiation, progression, and metastasis.
- Bidirectional communication between cancer cells and stromal cells within the TME drives tumor development.
- This interplay occurs via direct cell contact or secreted factors, influencing pro-tumor signaling pathways.
Purpose of the Study:
- To review recent advances in understanding breast cancer cell and neighbor cell interactions within the TME.
- To highlight the role of exosomes and circulating tumor cells in breast cancer metastasis.
- To discuss stromal cell markers for predicting patient survival and guiding treatment.
Main Methods:
- Literature review of current research on breast cancer TME interactions.
- Analysis of signaling pathways and cellular communication within the TME.
- Discussion of biomarkers and emerging therapeutic technologies.
Main Results:
- Multiple interactions between breast cancer cells and stromal cells (fibroblasts, endothelial cells, adipocytes, immune cells) coordinate metastasis.
- Exosomes and circulating tumor cells are key facilitators of breast cancer metastasis.
- Specific stromal cell markers show potential for predicting patient outcomes and informing treatment decisions.
Conclusions:
- The complex interactions within the breast cancer TME are critical regulators of metastasis.
- Targeting TME components and utilizing identified markers may lead to improved breast cancer therapies.
- Further technological advancements are expected to enhance clinical management of breast cancer patients.
Related Concept Videos
The Tumor Microenvironment
7.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Mitogens and the Cell Cycle
7.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K


